$0.00210
At close: Dec 19, 10:16 AM EDT
Comments
Loading...
TrivarX Analyst Ratings and Price Targets | OTC:MDBIF | Benzinga
TrivarX Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for TrivarX Corp from these most-recent analyst ratings.
Analyst Ratings for TrivarX
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for TrivarX (MDBIF) stock?
There is no price target for TrivarX
What is the most recent analyst rating for TrivarX (MDBIF)?
There is no analyst for TrivarX
When was the last upgrade for TrivarX (MDBIF)?
There is no last upgrade for TrivarX
When was the last downgrade for TrivarX (MDBIF)?
There is no last downgrade for TrivarX.
When is the next analyst rating going to be posted or updated for TrivarX (MDBIF)?
There is no next analyst rating for TrivarX.
Is the Analyst Rating TrivarX (MDBIF) correct?
There is no next analyst rating for TrivarX.
Browse analyst ratings and price targets on all stocks.
